# The Effects of mETHotrexate Therapy on ST Segment Elevation MYocardial InfarctionS (TETHYS Trial)

> **NCT01741558** · PHASE2 · UNKNOWN · sponsor: **Instituto de Cardiologia do Rio Grande do Sul** · enrollment: 80 (estimated)

## Conditions studied

- Myocardial Infarction

## Interventions

- **DRUG:** Methotrexate
- **DRUG:** Riboflavin

## Key facts

- **NCT ID:** NCT01741558
- **Lead sponsor:** Instituto de Cardiologia do Rio Grande do Sul
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-04
- **Primary completion:** 2014-08
- **Final completion:** 2014-12
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2013-04-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01741558

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01741558, "The Effects of mETHotrexate Therapy on ST Segment Elevation MYocardial InfarctionS (TETHYS Trial)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01741558. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
